S. 1862In Committee
ORPHAN Cures Act
Modifies Medicare drug price negotiation rules for orphan drugs by changing market approval timing and expanding the orphan drug exclusion for rare disease treatments
Plain-English overview
What this bill does
Modifies Medicare drug price negotiation rules for orphan drugs by changing market approval timing and expanding the orphan drug exclusion for rare disease treatments
Key points
- Modify market approval calculations
- Exclude certain orphan drugs
Current status
Where it stands
Status
In Committee
Latest action
2025-05-22 — Read twice and referred to the Committee on Finance. (text: CR S3119)
Related context
Topics and policy areas
undefinedHealth